TC BioPharm Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • TC BioPharm's estimated annual revenue is currently $11.8M per year.(i)
  • TC BioPharm's estimated revenue per employee is $155,000

Employee Data

  • TC BioPharm has 76 Employees.(i)
  • TC BioPharm grew their employee count by -23% last year.

TC BioPharm's People

NameTitleEmail/Phone
1
Head QualityReveal Email/Phone
2
SVP OperationsReveal Email/Phone
3
Head FinanceReveal Email/Phone
4
Head ProductionReveal Email/Phone
5
Director Human ResourcesReveal Email/Phone
6
Senior Director FinanceReveal Email/Phone
7
Chief Operating Officer and FounderReveal Email/Phone
8
Chief Financial OfficerReveal Email/Phone
9
Director Product DevelopmentReveal Email/Phone
10
Senior Clinical DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.5M29-12%N/AN/A
#2
$15.7M1015%N/AN/A
#3
$87.9M40525%$292MN/A
#4
$2.6M47016%$631.7MN/A
#5
$14.9M96-8%$81MN/A
#6
$44.8M2310%$132.9MN/A
#7
$7.6M49-37%N/AN/A
#8
$17.4M11212%N/AN/A
#9
$334.6M134911%£994.6MN/A
#10
$830.2M53568%N/AN/A
Add Company

What Is TC BioPharm?

TC BioPharm’s mission is to develop and commercialise innovative cell-based products to treat disease, improving patient health and Quality of Life.\n\nTC BioPharm is a clinical development company with a cell-based product pipeline capable of treating a variety of disorders including cancer and severe viral infections. TCB is currently conducting Phase II/III clinical studies of its lead product, ImmuniCell®, in renal cell cancinoma, non-small cell lung cancer and melanoma patients. \n\nWe have a growing team based in our Glasgow and Edinburgh offices, alongside a wide range of scientific advisors, and partner organisations.

keywords:N/A

N/A

Total Funding

76

Number of Employees

$11.8M

Revenue (est)

-23%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TC BioPharm News

2022-04-17 - TC BioPharm Donates to Leukemia and Lymphoma Society in ...

TC BioPharm is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell...

2022-04-06 - TC BioPharm Receives CryoTC® Trademark for Proprietary ...

TC BioPharm is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell...

2022-03-22 - TC BioPharm to initiate Phase IIb/III trial of AML allogeneic cell ...

To detect, act on and destroy liquid and solid tumours, TC BioPharm leverages an allogeneic approach in unmodified and CAR-modified gamma-delta...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.8M76-4%N/A
#2
$15M77N/AN/A
#3
$7.5M787%N/A
#4
$16.6M79-1%N/A
#5
$11.6M80-14%N/A